Redoxica
| Private | |
| ISIN | 🆔 |
| Industry | Medical Devices Biotechnology Pharmaceutical |
| Founded 📆 | 2008 |
| Founder 👔 | Kundan Das |
| Headquarters 🏙️ | , Little Rock, Arkansas , U.S. |
Area served 🗺️ | |
Key people | Kundan Das (Founder & CEO) |
| Members | |
Number of employees | |
| 🌐 Website | redoxica |
| 📇 Address | |
| 📞 telephone | |
Redoxica is a global developer and manufacturer of biotechnology products, medical device, and pharmaceutical drugs used in biomedical research and healthcare located in Little Rock, Arkansas.[1] It was incorporated in June 2008 and has since expanded globally through an exclusive fulfillment partnership with Labscoop, a lab supply ordering application and has also partnered with Nikken SEIL Co., Ltd. in Japan to serve the Japanese market. Redoxica manufacturers products in the areas of alzheimer's, parkinson's, neuroscience, cancer research, and cardiovascular disease. The products developed and manufactured by Redoxica are created for laboratory research, clinical diagnosis, and surgical applications. The scientific research consumables and reagents offered by the company may be utilized in a wide range of applications including cell culture, Western blotting, DNA cloning, enzyme kinetics and in vitro or in vivo functional assays.[2]
History[edit]
Redoxica was founded by CEO, Kundan Das, who first introduced and commercialized antioxidant enzyme assay technologies for detecting thioredoxin activity and 2-cys-peroxiredoxin activity and later also introduced and commercialized for the first time mitochondrial complex enzyme kinetic assay technologies for the detection of Succinate Dehydrogenase (SDH), Aconitase, NADH Dehydrogenase, and Alpha-Ketoglutarate Dehydrogenase (α-KDH) using novel enzyme kinetic detection methods.[3]
References[edit]
- ↑ Little Rock Tech Park Announces First Tenants
- ↑ Peroxiredoxin-2 Protects against 6-Hydroxydopamine-Induced Dopaminergic Neurodegeneration via Attenuation of the Apoptosis Signal-Regulating Kinase (ASK1) Signaling Cascade
- ↑ Thioredoxin-2 Inhibits Mitochondrial ROS Generation and ASK1 Activity to Maintain Cardiac Function
External links[edit]
This article "Redoxica" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Redoxica. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
